Latest News

New drugs offer hope for migraine prevention

Two new studies may offer hope for people with migraines. Both studies involve drugs that are aimed at preventing migraine attacks from occurring, rather than stopping the attacks once they have started. These studies are the first to test monoclonal antibodies for the prevention of migraine, and both are directed against a relatively new target in migraine prevention, the calcitonin gene-related peptide, or CGRP. CGRP has been thought to be important in migraine, but never have drugs been developed to specifically target the protein.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Sharing knowledge positively impacts innovation in retail

  • Cancer survivors who smoke perceive less risk from tobacco

  • Mental Health: New approach 'has positive impact'

  • Extracurricular sports produce disciplined preteens

  • 70 percent of college students stressed about finances

  • Novel DNA repair mechanism brings new horizons

  • REM sleep critical for young brain development; medication interferes

  • How the stress hormone cortisol reinforces traumatic memories

  • Documenting how dementia sufferers benefit from GPS

  • Prion trials and tribulations: Finding the right tools and experimental models

  •